Angina patients with no obstructive CAD had no worse outcomes over 15 years, perhaps because they got the care they needed.
The US Food and Drug Administration has approved the use of lerodalcibep (Lerochol) to reduce LDL cholesterol alongside ...
The self-administered treatment rapidly converts patients into sinus rhythm and may reduce trips to the hospital.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback